RESULTS	The mean change in the International Prostate Symptom Score from baseline at endpoint was -3.6 and -3.4 with alfuzosin 10 mg and 15 mg , respectively , compared with -1.6 with placebo ( alfuzosin 10 mg versus placebo , P = 0.001 ; alfuzosin 15 mg versus placebo , P = 0.004 ) .\